三個皮匠報告
政策庫
new
付費
搜索

Paxlovid全球仿制藥及原料藥授權情況-行業數據

Paxlovid全球仿制藥及原料藥授權情況
Paxlovid全球仿制藥及原料藥授權情況
資料來源：《A Sustainable Synthesis of the SARS-CoV-2 Mpro Inhibitor Nirmatrelvir, the Active Ingredient in Paxlovid 》（著作權屬于Joseph R. A. Kincaid, Juan C. Caravez,Karthik S. Iyer, Rahul D. Kavthe, Nico Fleck, Donald H.Aue, and Bruce H. Lipshutz），東興證券研究所
行業數據 下載Excel 下載圖片 原圖定位
圖片屬性
圖片格式：PNG 圖片大?。?968KB 圖片尺寸：2775*1358
同報告圖片
 / 62
Paxlovid全球仿制藥及原料藥授權情況_第1頁
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
Paxlovid全球仿制藥及原料藥授權情況_第2頁
Paxlovid全球仿制藥及原料藥授權情況_第3頁
Paxlovid全球仿制藥及原料藥授權情況_第4頁
Paxlovid全球仿制藥及原料藥授權情況_第5頁
Paxlovid全球仿制藥及原料藥授權情況_第6頁
Paxlovid全球仿制藥及原料藥授權情況_第7頁
Paxlovid全球仿制藥及原料藥授權情況_第8頁
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
Paxlovid全球仿制藥及原料藥授權情況_第9頁
Paxlovid全球仿制藥及原料藥授權情況_第10頁
Paxlovid全球仿制藥及原料藥授權情況_第11頁
Paxlovid全球仿制藥及原料藥授權情況_第12頁
5oqx5q2J77yM5oiR5peg5rOV5o+Q5Y+W5Zu+54mH5Lit55qE5pWw5o2u5bm255Sf5oiQ6KGo5qC844CC
Paxlovid全球仿制藥及原料藥授權情況_第13頁
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
Paxlovid全球仿制藥及原料藥授權情況_第14頁
Paxlovid全球仿制藥及原料藥授權情況_第15頁
Paxlovid全球仿制藥及原料藥授權情況_第16頁
fCDlm740M++8mui+ieeRnnBheGxvdmlk6ZSA5ZSu6aKE5rWLIHwKfCAtLS0gfAp8IHwgMjAyMkgxIHwgMjAyMlEz6aKE6K6h5YC8IHwgMjAyMlE06aKE6K6h5YC8IHwgMjAyMkUgfAp8IFBheGxvdmlkIHwgOTbkur/nvo7lhYMgfCA3NC405Lq/576O5YWDIHwgNDkuNuS6v+e+juWFgyB8IDIyMOS6v+e+juWFgyB8CgrotYTmlpnmnaXmupDvvJrovonnkZ7liLboja8yMDIy5bm05Y2K5bm05bm05oql77yM5Lic5YW06K+B5Yi456CU56m25omA
Paxlovid全球仿制藥及原料藥授權情況_第17頁
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
Paxlovid全球仿制藥及原料藥授權情況_第18頁
Paxlovid全球仿制藥及原料藥授權情況_第19頁
fCAgfCDljp/mlpkgfCDlt6XoibogfCDkuqflk4EgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8CnwgKEEpIHwg5LiN5Y+v5YaN55Sf5Y6f5paZIHwg5YyW5a2m6YW25rOVIHwgTC3kuJnmsKjphbggfAp8IChCKSB8IOWPr+WGjeeUn+WOn+aWmSB8IOebtOaOpeWPkemFtSB8IOWFieWtpue6r0wt5LiZ5rCo6YW4IHwKCui1hOaWmeadpea6kO+8muOAik1ldGFib2xpYyBlbmdpbmVlcmluZyBvZiBtaWNyb29yZ2FuaXNtcyBmb3IgTC1hbGFuaW5lIHByb2R1Y3Rpb27jgIs=
Paxlovid全球仿制藥及原料藥授權情況_第20頁
Paxlovid全球仿制藥及原料藥授權情況_第21頁
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
Paxlovid全球仿制藥及原料藥授權情況_第22頁
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
Paxlovid全球仿制藥及原料藥授權情況_第23頁
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
Paxlovid全球仿制藥及原料藥授權情況_第24頁
Paxlovid全球仿制藥及原料藥授權情況_第25頁
Paxlovid全球仿制藥及原料藥授權情況_第26頁
Paxlovid全球仿制藥及原料藥授權情況_第27頁
| 时间 | 全基因组规模定制工程 | 系统代谢工程 | 经典代谢工程 | 诱变育种 |
|------|----------------------|--------------|--------------|----------|
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |              |          |
|      |                      |              |
Paxlovid全球仿制藥及原料藥授權情況_第28頁
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
Paxlovid全球仿制藥及原料藥授權情況_第29頁
Paxlovid全球仿制藥及原料藥授權情況_第30頁
Paxlovid全球仿制藥及原料藥授權情況_第31頁
Paxlovid全球仿制藥及原料藥授權情況_第32頁
Paxlovid全球仿制藥及原料藥授權情況_第33頁
fCDlubTku70gICB8IDIwMTcgIHwgMjAxOCAgfCAyMDE5ICB8IDIwMjAgIHwgMjAyMSAgfCAyMDIyRSB8IDIwMjNFIHwgMjAyNEUgfCAyMDI1RSB8IDIwMjZFIHwgMjAyN0UgfAp8LS0tLS0tLS18LS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18LS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18LS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18LS0tLS0tLXwtLS0tLS0tfAp8IOW4guWcuuinhOaooSB8IDQwNS45IHwgNDYwLjMgfCA1MTcuOCB8IDU0NS40IHwgNjQ1LjQgfCA3MzkgICB8IDg1Ni45IHwgOTkyLjkgfCAxMTQ4Ljd8IDEzMDYuN3wgMTU2MS40fAoK6LWE5paZ5p2l5rqQ77ya5byX6Iul5pav54m55rKZ5Yip5paH77yM5Lic5YW06K+B5Yi456CU56m25omA
Paxlovid全球仿制藥及原料藥授權情況_第34頁
Paxlovid全球仿制藥及原料藥授權情況_第35頁
Paxlovid全球仿制藥及原料藥授權情況_第36頁
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
Paxlovid全球仿制藥及原料藥授權情況_第37頁
fCDlubTku70gICB8IDIwMTcgfCAyMDE4IHwgMjAxOSB8IDIwMjAgfCAyMDIxIHwgMjAyMkUgfCAyMDIzRSB8IDIwMjRFIHwgMjAyNUUgfCAyMDI2RSB8IDIwMjdFIHwKfC0tLS0tLS0tfC0tLS0tLXwtLS0tLS18LS0tLS0tfC0tLS0tLXwtLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18Cnwg5pWw5YC8ICAgfCA4LjIgIHwgMTAgICB8IDEyLjQgfCAxNCAgIHwgMTcuOSB8IDIxLjIgICB8IDI2LjYgICB8IDMzLjIgICB8IDQxLjQgICB8IDUxLjcgICB8IDY1LjUgICB8
Paxlovid全球仿制藥及原料藥授權情況_第38頁
Paxlovid全球仿制藥及原料藥授權情況_第39頁
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
Paxlovid全球仿制藥及原料藥授權情況_第40頁
Paxlovid全球仿制藥及原料藥授權情況_第41頁
fCDml6XmnJ8gfCBUb3RhbCBWQyAoJE0pIHwKfC0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tfAp8IDIwMDktUTEgfCAwLjAgfAp8IDIwMDktUTIgfCAwLjAgfAp8IC4uLiB8IC4uLiB8CnwgMjAyMS1RNCB8IDAuMCB8CgrotYTmlpnmnaXmupDvvJpTaW5vQmlvdGVjaCwg5Lic5YW06K+B5Yi456CU56m25omA
Paxlovid全球仿制藥及原料藥授權情況_第42頁
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
Paxlovid全球仿制藥及原料藥授權情況_第43頁
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
Paxlovid全球仿制藥及原料藥授權情況_第44頁
Paxlovid全球仿制藥及原料藥授權情況_第45頁
Paxlovid全球仿制藥及原料藥授權情況_第46頁
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
Paxlovid全球仿制藥及原料藥授權情況_第47頁
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
Paxlovid全球仿制藥及原料藥授權情況_第48頁
Paxlovid全球仿制藥及原料藥授權情況_第49頁
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
Paxlovid全球仿制藥及原料藥授權情況_第50頁
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
Paxlovid全球仿制藥及原料藥授權情況_第51頁
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
Paxlovid全球仿制藥及原料藥授權情況_第52頁
Paxlovid全球仿制藥及原料藥授權情況_第53頁
5Lul5LiL5piv5qC55o2u5oKo55qE6KaB5rGC55Sf5oiQ55qE6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgp8IOS6p+WTgSAgfCDlubTku70gfCDliIbnsbsgICAgICAgfCDljZXkvY0gfCDku7fmoLzvvIjkurrmsJHluIHvvIkgfAp8LS0tLS0tLXwtLS0tLS18LS0tLS0tLS0tLS0tfC0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tfAp8IOWPguiMuCAgfCAyMDE2IHwg5Yqf6IO95oCn6aOf5ZOBIHwgMSAgICB8IDU3MOWFgyAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrlt6jlrZDnlJ/nianmi5vogqHkuabvvIzkuJzlhbTor4HliLjnoJTnqbbmiYA=
Paxlovid全球仿制藥及原料藥授權情況_第54頁
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
Paxlovid全球仿制藥及原料藥授權情況_第55頁
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
Paxlovid全球仿制藥及原料藥授權情況_第56頁
Paxlovid全球仿制藥及原料藥授權情況_第57頁
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
Paxlovid全球仿制藥及原料藥授權情況_第58頁
fCBCcmVha3Rocm91Z2ggQ2FwYWJpbGl0eSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCBNaWxlc3RvbmUgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tIHwgLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLSB8CnwgQmlvbG9naWNhbCBzeW50aGVzaXMgYW5kL29yIHBvbHltZXJpemF0aW9uIG9mIG5vbi1uYXR1cmFsIGFuZC9vciBhYmlvdGljIGNoZW1pY2FsIG1vbm9tZXJzLCBleGNsdWRpbmcgYW1pbm8gYWNpZHMuIHwgSWRlbnRpZnkgYW5kIGVuZ2luZWVyIGVuenltZXMgdG8gcmVjb2duaXplIGFuZCBwb2x5bWVyaXplIGNvbnZlbnRpb25hbCBjaGVtaWNhbCBtb25vbWVycyAoZS5nLiwgYWNyeWxhbWlkZSkuICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IERldmVsb3AgbWV0YWJvbGljIHBhdGh3YXlzIHRvIHlpZWxkIGNoaXJhbCBjeWNsaWMgbW9ub21lcnMgYW1lbmFibGUgdG8gcmluZy1vcGVuaW5nIHBvbHltZXJpemF0aW9uIHwgRW5hYmxlIHZpbnlsIG1vbm9tZXIgcHJvZHVjdGlvbiBieSBlbmdpbmVlcmluZyBtZXRhYm9saWMgcGF0aHdheXMgZm9yIGluIHNpdHUgcG9seW1lcml6YXRpb24gcmVhY3Rpb25zLiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgRGVtb25zdHJhdGUgc2lkZSBjaGFpbiBtb2RpZmljYXRpb24gb2YgcG9seW1lcmljIHNjYWZmb2xkcyBieSBiaW9sb2dpY2FsIHJlYWN0aW9ucyBjYXRhbHl6ZWQgYnkgbGl2aW5nIGNlbGxzLiB8IEV4cGFuZCB0aGUgbGlicmFyeSBvZiBjaGVtaWNhbCBtb25vbWVycyBwb2x5bWVyaXphYmxlIGJ5IGV2b2x2ZWQgZW56eW1lcy4gICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IEh5YnJpZCBjaGVtaWNhbCBhbmQgYmlvbG9naWNhbCBzeW50aGVzaXMgbWV0aG9kcy4gICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IEVuZ2luZWVyIGNvbXBsZXggb3J0aG9nb25hbCB0cmFuc2xhdGlvbiBzeXN0ZW1zLCBpbmNsdWRpbmcgZW5naW5lZXJlZCBvcnRob2dvbmFsIHJpYm9zb21lcywgZm9yIHNpdGUtZGlyZWN0ZWQgaW5jb3Jwb3JhdGlvbiBvZiBub3ZlbCAobm9uLWFtaW5vIGFjaWQpIGNoZW1pc3RyaWVzIGludG8gcG9seW1lcnMuICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCBDaGFyYWN0ZXJpemUgYW5kIGltcHJvdmUgdGhlIGVuenltb2xvZ3kgb2Ygb3J0aG9nb25hbCB0cmFuc2xhdGlvbiBzeXN0ZW1zIChPVFNzKSBmb3Igc2l0ZS1kaXJlY3RlZCBpbmNvcnBvcmF0aW9uIG9mIG5vdmVsIGNoZW1pc3RyaWVzIGludG8gcG9seW1lcnMuICAgfCBFbmFibGUgY29tcGxleCBwb2x5bWVyIHByb2R1Y3Rpb24gKGUuZy4sIGNvLXBvbHltZXJzLCBzZXF1ZW5jZS1jb250cm9sbGVkIHBvbHltZXJzLCBicnVzaGVkIHBvbHltZXJzKSB3aXRoIGVuenltYXRpYyBzeXN0ZW1zLiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCBGdWxsIGludGVncmF0aW9uIG9mIGhldGVyb2dlbmVvdXMgY2hlbWljYWwgYW5kIGJpb2xvZ2ljYWwgY2F0YWx5c2lzIGluIG1vZHVsYXIgcGxhdGZvcm1zIHRoYXQgYXJlIHN0YWJsZSBhZnRlciBsb25nLXRlcm0gc3RvcmFnZSBhbmQgZmFjaWxpdGF0ZSBwcm9kdWN0IHN3aXRjaGluZy4gfCBFbmFibGUgaHlicmlkIGZsb3cgY2hlbWlzdHJ5LWJpb2NhdGFseXRpYyBzeW50aGVzaXMgc3lzdGVtcy4gICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCBFbmFibGUgcmV0cm9zeW50aGVzaXMgb2YgbWF0ZXJpYWxzIHdpdGggZGVzaXJlZCBwcm9wZXJ0aWVzLCBzdWNoIGFzIHRoZXJtYWwgY29uZHVjdGl2aXR5IG9yIGVsYXN0aWNpdHkuICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDIwMjLlubTvvIzlj5HnjrDlkozorr7orqHphbbku6Xor4bliKvlkozogZrlkIjluLjop4TljJblrabljZXkvZPvvIzlpoLkuJnng6/phbDog7rnrYnvvJvlvIDlj5Hku6PosKLpgJTlvoTku6XkuqfnlJ/pgILlkIjkuo7lvIDnjq/ogZrlkIjnmoTmiYvmgKfnjq/nirbljZXkvZPvvJvpgJrov4fmtLvnu4bog57lgqzljJbnmoTnlJ/nianlj43lupTmnaXnpLrojIPogZrlkIjnianmlK/mnrbnmoTkvqfpk77kv67ppbDjgIIgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDI15bm077yM6YCa6L+H6K6+6K6h55So5LqO5Y6f5L2N6IGa5ZCI5Y+N5bqU55qE5Luj6LCi6YCU5b6E77yM5a6e546w5LmZ54Ov5Z+65Y2V5L2T55qE55Sf5Lqn77yb5omp5bGV5Y+v6YCa6L+H6L+b5YyW6YW26IGa5ZCI55qE5YyW5a2m5Y2V5L2T5bqT77yb6K6+6K6h5aSN5p2C55qE5q2j5Lqk57+76K+R57O757uf77yM5YyF5ous5bel56iL5YyW55qE5q2j5Lqk5qC457OW5L2T77yM55So5LqO5bCG5paw55qE77yI6Z2e5rCo5Z+66YW477yJ5YyW5a2m54mp6LSo5a6a5ZCR57uT5ZCI5Yiw6IGa5ZCI54mp5Lit44CCICAgICAgICAgICAgICAgICAgICAgICAgICAgfCAyMDMw5bm077yM5Yip55So6YW257O757uf5a6e546w5aSN5p2C6IGa5ZCI54mp55Sf5Lqn77yM5aaC5YWx6IGa5ZCI54mp44CB5bqP5YiX5Y+v5o6n6IGa5ZCI54mp44CB5ouJ5Lid6IGa5ZCI54mp562J44CCICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8mkVCUkPvvIzkuJzlhbTor4HliLjnoJTnqbbmiYA=
Paxlovid全球仿制藥及原料藥授權情況_第59頁
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
Paxlovid全球仿制藥及原料藥授權情況_第60頁
fCDlubQgfCDmiJDmnKwgfAp8LS0tLS0tfC0tLS0tLS0tfAp8IDIwMDEgfCA5NTAwMDAwMDAgfAp8IDIwMDMgfCA0MDAwMDAwMDAgfAp8IDIwMDUgfCAxNDAwMDAwMDAgfAp8IDIwMDcgfCA3MDAwMDAwIHwKfCAyMDA5IHwgNzAwMDAgfAp8IDIwMTEgfCA4MDAwIHwKfCAyMDEzIHwgNTAwMCB8CnwgMjAxNSB8IDEyMDAgfAp8IDIwMTcgfCAxMTAwIHwKfCAyMDE5IHwgODA5IHwKfCAyMDIwIHwgNjM3IHwKfCAyMDIxIHwgNjIyIHwKCui1hOaWmeadpea6kO+8mk5IR1JJIEdlbm9tZSBTZXF1ZW5jaW5nIFByb2dyYW3vvIzkuJzlhbTor4HliLjnoJTnqbbmiYA=
Paxlovid全球仿制藥及原料藥授權情況_第61頁
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
Paxlovid全球仿制藥及原料藥授權情況_第62頁
fCDlubTku70gfCBzc0ROQSB8IGRzRE5BIHwKfC0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwKfCAyMDA2IHwgMC4yNSAgIHwgMSAgICAgIHwKfCAyMDE5IHwgMC4wNCAgIHwgMC4wOSAgIHwKCui1hOaWmeadpea6kO+8mnd3dy5zeW50aGVzaXMuY2M7IHZlbmRvciB3ZWJzaXRlcywg5Lic5YW06K+B5Yi456CU56m25omA
Paxlovid全球仿制藥及原料藥授權情況_第63頁
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
所屬報告： 醫藥行業：合成生物學綠色造物智創未來-220927（98頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站